These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1565178)
21. Effect of the dialysis membrane in the treatment of patients with acute renal failure. Hakim RM; Wingard RL; Parker RA N Engl J Med; 1994 Nov; 331(20):1338-42. PubMed ID: 7935703 [TBL] [Abstract][Full Text] [Related]
22. Growing bone cysts in long-term hemodialysis. Gielen JL; van Holsbeeck MT; Hauglustaine D; Verresen L; Verbeken E; Baert AL; Meeus L; Vandevoorde P; Michielsen P; Coral A Skeletal Radiol; 1990; 19(1):43-9. PubMed ID: 2326655 [TBL] [Abstract][Full Text] [Related]
23. [Current aspects of the osteoarticular pathology of hemodialysis patients. Results and discussion of a rheumatological survey]. Foissac-Gegoux P; Flipo RM; Hardouin P; Dumont A; Duquesnoy B; Lecomte-Houcke M; Delcambre B Nephrologie; 1986; 7(4):157-63. PubMed ID: 3796785 [TBL] [Abstract][Full Text] [Related]
24. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis? Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517 [TBL] [Abstract][Full Text] [Related]
25. [Distribution of platelet membrane phospholipids in patients chronically hemodialyzed using cuprophane and cellulose acetate membranes]. Krawczyk W; Marczewski K; Ledwozyw A; Dmoszyńska A Pol Arch Med Wewn; 1994 Jul; 92(1):41-6. PubMed ID: 7971476 [TBL] [Abstract][Full Text] [Related]
27. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism. Oprisiu R; Bolosiu H; Boca I; Theodoru C; Elefterescu R; Brazier M; el Esper I; Leflon P; Ledeme C; Fournier A; Heinze V Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527 [TBL] [Abstract][Full Text] [Related]
28. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients. Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492 [TBL] [Abstract][Full Text] [Related]
29. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Zaoui P; Green W; Hakim RM Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197 [TBL] [Abstract][Full Text] [Related]
30. [Osteoarticular amyloidosis caused by dialysis]. Orzincolo C; Bedani PL; Scutellari PN; Cardona P; Farinelli A; Vita G Radiol Med; 1988; 76(1-2):38-43. PubMed ID: 3399708 [TBL] [Abstract][Full Text] [Related]
31. Development of adenocarcinoma and acquired cystic disease of the kidney in hemodialysis patients. Ishikawa I Princess Takamatsu Symp; 1987; 18():77-86. PubMed ID: 3333499 [TBL] [Abstract][Full Text] [Related]
32. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Bonomini M; Stuard S; Carreno MP; Settefrati N; Santarelli P; Haeffner-Cavaillon N; Albertazzi A Nephron; 1997; 75(4):402-11. PubMed ID: 9127326 [TBL] [Abstract][Full Text] [Related]
33. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Docci D; Capponcini C; Mengozzi S; Baldrati L; Neri L; Feletti C Nephron; 1995; 69(3):323-6. PubMed ID: 7753268 [TBL] [Abstract][Full Text] [Related]
34. Platelet activation on hemodialysis: influence of dialysis membranes. Cases A; Reverter JC; Escolar G; Sanz C; Lopez-Pedret J; Revert L; Ordinas A Kidney Int Suppl; 1993 Jun; 41():S217-20. PubMed ID: 8320925 [TBL] [Abstract][Full Text] [Related]
35. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177 [TBL] [Abstract][Full Text] [Related]
36. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients. Schiffl H Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290 [TBL] [Abstract][Full Text] [Related]
37. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097 [TBL] [Abstract][Full Text] [Related]
38. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression. Zaoui PM; Stone WJ; Hakim RM Kidney Int; 1990 Nov; 38(5):962-8. PubMed ID: 2266681 [TBL] [Abstract][Full Text] [Related]
39. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study. Danielson BG; Hällgren R; Venge P Blood Purif; 1986; 4(1-3):147-50. PubMed ID: 3524607 [TBL] [Abstract][Full Text] [Related]
40. Preliminary report on complement activating potential of polycarbonate membrane. Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]